{
  "id": 1995466,
  "title": "FDA approves Regeneron’s garetosmab for disease that turns tissue to bone",
  "url": "https://urgent.news/2026/08/19/fda-approves-regenerons-garetosmab-for-disease-that-turns-tissue-to",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-19T18:42:46.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/fda-approves-regenerons-garetosmab-for-disease-that-turns-tissue-to-bone/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The US FDA has approved Regeneron's treatment for fibrodysplasia ossificans progressiva (FOP), a rare disease that causes muscle and connective tissue to be replaced with bone. The approved treatment is called garetosmab, also referred to as Pasatru by STAT News.\n\nAccording to STAT News, people with FOP typically rely on wheelchairs by age 25 as bone accumulation locks up their limbs, and only some live into their 50s. The hope is that garetosmab can help patients maintain their mobility and live longer.\n\nThe approval was based on a pivotal trial led by Richard Keen of London’s Royal National Orthopaedic Hospital. Keen stated that the treatment \"almost completely stops the new [bone] forming, and therefore their condition will not deteriorate.\"",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval",
        "url": "https://urgent.news/2026/08/19/stat-regeneron-drug-for-disease-that-causes-dangerous-bone-growth",
        "published": "2026-08-19T17:02:11.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}